It is thought that the worst progression of proximal tumours could be attributed in part to the frequency with which genetic alterations, such as BRAF and KRAS mutations, microsatellite instability, and CpG island methylator phenotype, are detected [17]. The gene discussed is BRAF; the disease is neoplasm.